12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Embecta (NASDAQ:EMBC) shares increased by 37.7% to $14.14 during Thursday’s regular session. The company’s market cap stands…
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
NeuroPace (NASDAQ:NPCE) has been analyzed by 6 analysts in the last three months, revealing a diverse range of…
Breaking Down NeuroPace: 6 Analysts Share Their Views
6 analysts have expressed a variety of opinions on NeuroPace (NASDAQ:NPCE) over the past quarter, offering a diverse…
Expert Ratings for NeuroPace
Over the past 3 months, 5 analysts have published their opinion on NeuroPace (NASDAQ:NPCE) stock. These analysts are…
Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position
Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive neurostimulation device (RNS).
Expert Ratings for NeuroPace
Analysts have provided the following ratings for NeuroPace (NASDAQ:NPCE) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
NeuroPace Sees FY23 Revenue $62.5M-$63.5M Vs $60.23M Est.
Full Year 2023 Financial GuidanceIncreased total revenue guidance to range between $62.5 million and $63.5 million, representing growth of 37% to 39% over 2022, as compared to previous guidance of $59 million to $61
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Senti Biosciences (NASDAQ:SNTI) shares increased by 187.7% to $0.84 during Monday’s after-market session. Trading volume for this…
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell
• Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Top 5 Health Care Stocks That May Fall Off A Cliff
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.